Martin Shkreli, the pharmaceutical executive who was widely criticized for jacking up the price of a drug mainly used by cancer and HIV-AIDS patients by more than 5,000 percent, is the secret buyer of a one-of-a-kind Wu-Tang Clan album, Bloomberg Business reported Wednesday. The 32-year-old founder of Turing Pharmaceuticals, who in September increased the price of the drug Daraprim to $750 per tablet, up from $13.50, purchased the iconic hip-hop group's album "The Wu -- Once Upon a Time in Shao...
'Pharma Bro' Martin Shkreli Bought Lone Copy Of Wu-Tang Clan Album For $2 Million
The Huffington Post - 10 Dec 2015 04:06
Martin Shkreli, the pharmaceutical executive who was widely criticized for jacking up the price of a drug mainly used by cancer and HIV-AIDS patients by more than 5,000 percent, is the secret buyer of a one-of-a-kind Wu-Tang Clan album, Bloomberg Business reported Wednesday. The 32-year-old founder of Turing Pharmaceuticals, who in September increased the price of the drug Daraprim to $750 per tablet, up from $13.50, purchased the iconic hip-hop group's album "The Wu -- Once Upon a Time in Shao...
Share this Article
Recommended